In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. (Q50882019)

From Wikidata
Jump to navigation Jump to search
scientific article published on 19 July 2017
edit
Language Label Description Also known as
English
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.
scientific article published on 19 July 2017

    Statements

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit